David A. SCHEINBERG,Thomas J. GARDNER,Derek S. TAN,Jonghan LEE
申请号：
US16627270
公开号：
US20200268794A1
申请日:
2018.07.02
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Provided herein are compositions and methods for adoptive cell therapy comprising engineered immune cells that express an antigen-targeted chimeric antigen receptor and a prodrug converting enzyme for the treatment of inflammation, inflammatory diseases, or pathogenic infections.
